Standard Biotools (LAB) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16,142.00 |
| Dec 31, 2025 | 5,669.00 |
| Sep 30, 2025 | -10,570.00 |
| Jun 30, 2025 | -9,048.00 |
| Mar 31, 2025 | -297.00 |
| Dec 31, 2024 | -4,174.00 |
| Sep 30, 2024 | -9,587.00 |
| Jun 30, 2024 | -16,296.00 |
| Mar 31, 2024 | -7,117.00 |
| Dec 31, 2023 | -3,808.00 |
| Sep 30, 2023 | -3,384.00 |
| Jun 30, 2023 | -2,010.00 |
| Mar 31, 2023 | 2,657.00 |
| Dec 31, 2022 | -7,552.00 |
| Sep 30, 2022 | -6,640.00 |
| Jun 30, 2022 | -12,944.00 |
| Mar 31, 2022 | -2,614.00 |
| Sep 30, 2021 | -10,746.00 |
| Jun 30, 2021 | -9,314.00 |
| Mar 31, 2021 | -2,964.00 |
| Dec 31, 2020 | -1,336.00 |
| Sep 30, 2020 | 3,277.00 |
| Jun 30, 2020 | 1,909.00 |
| Mar 31, 2020 | -13,171.00 |
| Dec 31, 2019 | -360.00 |
| Sep 30, 2019 | 1,224.00 |
| Jun 30, 2019 | -1,043.00 |
| Mar 31, 2019 | -1,969.00 |
| Dec 31, 2018 | -853.00 |
| Sep 30, 2018 | -399.00 |
| Jun 30, 2018 | -34.00 |
| Mar 31, 2018 | -5,349.00 |
| Dec 31, 2017 | 2,896.00 |
| Sep 30, 2017 | -540.00 |
| Jun 30, 2017 | 213.00 |
| Mar 31, 2017 | 2,837.00 |
| Dec 31, 2016 | -2,297.00 |
| Sep 30, 2016 | -4,234.00 |
| Jun 30, 2016 | 8,360.00 |
| Mar 31, 2016 | -1,415.00 |
| Dec 31, 2015 | 886.00 |
| Sep 30, 2015 | 84,234.00 |